Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tumor-informed ctDNA Testing for Minimal Residual Disease Monitoring Following Curative-intent Treatment of Squamous Cell Carcinoma of the Head and Neck.

NCT06606028 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT06606028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06606028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tumor-informed ctDNA Testing for Minimal Residual Disease Monitoring Following Curative-intent Treatment of Squamous Cell Carcinoma of the Head and Neck.
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Recruiting
Start date
October 9, 2024
Completion date
December 30, 2029
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous squamous cell carcinoma (cscc), squamous cell carcinoma head and neck cancer (hnscc), squamous cell carcinoma of head and neck, squamous cell carcinoma of skin